Answers are grounded in this paper and cite their sources.
Evidence is given for the existence of leu-enkephalin binding activity on the cell surface of a human lymphoid T line. Our data suggest that binding is due to receptor structures which in all likelyhood are lipoproteic, as is already known to be the case with the receptors present in the mammalian brain. In spite of these similarities, however, lymphocytes exhibit anomalous specificity as far as the binding toward opioid alkaloids and their inhibitors is concerned.
No takes yet. Share an insight, caveat, or question.
Ausiello et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: